News
Stockhead on MSN
‘Tough nut to crack’, but expert tips Alterity’s MSA drug as potential game changer
A leading neurologist involved in development of Alterity's lead compound ATH434 believes it could be a game changer for sufferers of MSA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback